Invasive Pulmonary Aspergillosis and Tuberculosis Complicated by Hemophagocytic Lymphohistiocytosis - Sequelae of COVID-19 in a Liver Transplant Recipient

Liver transplant recipients are at an increased risk of opportunistic infections due to the use of immunosuppression. Coronavirus disease of 2019 (COVID-19) increases the risk of these infections further due to associated immune dysfunction and the use of high-dose steroids. We present a case of a l...

Descripción completa

Detalles Bibliográficos
Autores principales: Gandotra, Akash, Mehtani, Rohit, Premkumar, Madhumita, Duseja, Ajay, De, Arka, Mallik, Nabhajit, Durgadevi, S., Das, Ashim, Kalra, Naveen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653520/
https://www.ncbi.nlm.nih.gov/pubmed/34898957
http://dx.doi.org/10.1016/j.jceh.2021.12.002
Descripción
Sumario:Liver transplant recipients are at an increased risk of opportunistic infections due to the use of immunosuppression. Coronavirus disease of 2019 (COVID-19) increases the risk of these infections further due to associated immune dysfunction and the use of high-dose steroids. We present a case of a liver transplant recipient who developed disseminated tuberculosis and invasive pulmonary aspergillosis complicated by acquired hemophagocytic lymphohistiocytosis after recovering from severe COVID-19.

Ejemplares similares